Hangzhou ThinHeal Pharma-Tech Co., Ltd.

Thinheal, headquartered in Hangzhou, China, serves as your trusted partner in end-to-end cGMP-compliant peptide solutions—from conceptual development to commercial-scale manufacturing. Our team brings decades of expertise in pharmaceutical R&D, with a proven track record of successfully launched products across domestic and international markets, including the United States, EU, and Japan. Operational excellence is ensured through our dedicated cGMP peptide production subsidiary Zhejiang Talsn Biopharma Co., Ltd., strategically located in Shaoxing Binhai New Area, Zhejiang Province. The state-of-the-art 250,000 sq. ft. facility houses seven large-scale manufacturing lines fully compliant with the latest cGMP standards of the US FDA, and China NMPA. This vertically integrated infrastructure enables us to deliver globally harmonized quality while maintaining agile responsiveness to client needs.